IlluminOss Medical has launched its IlluminOss Bone Stabilization System that is designed to be used in skeletally mature patients for treating arm fractures.
“We are thrilled to announce the commercial launch of the IlluminOss System,” Jeff Bailey, CEO of IlluminOss Medical, said. “IlluminOss is truly an innovative addition to fragility fracture treatment and we have been receiving outstanding feedback from our orthopedic surgeon customers regarding its potential to make a difference for patients with poor quality bone. Entry into the multi-billion dollar U.S. trauma market marks a significant milestone for our company.”
The system uses an expandable balloon implant that is delivered through a minimally invasive way in a small incision. It is designed to support poor quality or compromised humerus, radius and ulna bones. The system is able to conform to the shape of a patient’s intramedullary bone canal when infused with a monomer. Visible blue lights cure the implant immediately to stabilize the bone.
Surgeons who have used the IlluminOss Bone Stabilization System so far have reported reduced hospital stays, shorter procedure times, less post-operative pain and a reduction in pain medication.
“IlluminOss provides an exciting new option in fracture repair for difficult-to-treat osteoporotic or other patients with compromised bone, and is a much-needed addition to conventional treatment with nails, plates and screws,” Dr. Mark Goodman at the University of Pittsburgh Medical Center, said. “The fact that this unique technology was designed specifically for use in patients with compromised bone enables surgeons to create a conforming implant for each individual patient and is a game-changer in fracture repair.”